Stefania Russo - Concepedia

Author

Stefania Russo

National Center for Oncological Hadrontherapy ORCID

Also Known As

Lloyd’s Register EMEA, UK, ROSSI, Luigi, Russo, Stefania, S RUSSO, S Russo, S. Russo, S. Russo⁎, S.M Russo, S.M. Russo, STEFANIA RUSSO

238

Publications

3.2K

Citations

H-Index

120

Concepts

All Affiliations

National Center for Oncological Hadrontherapy Istituti di Ricovero e Cura a Carattere Scientifico University of Udine European Institute of Oncology University of Milan

About

Stefania Russo is an author at National Center for Oncological Hadrontherapy specializing in medicine, radiation oncology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	16	25	821
2	Health Sciences	11	12	452
3	Engineering	4	4	73
4	Education	1	1	14
5	Natural Sciences	1	1	12

Stefania Russo

Publications

2.9K

Citations

H-Index

Page 1

	Year	Citations
Measures of Outcome in Metastatic Breast Cancer: Insights From a Real-World Scenario Marta Bonotto, Lorenzo Gerratana, Elena Poletto, The Oncologist	2014	283
Spatial predictors of immunotherapy response in triple-negative breast cancer Xiao Qian Wang, Esther Danenberg, Chiun‐Sheng Huang, Nature	2023	278
Baseline staging tests after a new diagnosis of breast cancer: further evidence of their limited indications Fabio Puglisi, Alessandro Follador, Alessandro Marco Minisini, Annals of Oncology Baseline Staging TestsBreast OncologyCancer DetectionCancer ScreeningMedicine	2005	158
Abstract GS3-04: Pathologic complete response (pCR) to neoadjuvant treatment with or without atezolizumab in triple negative, early high-risk and locally advanced breast cancer. NeoTRIPaPDL1 Michelangelo randomized study Luca Gianni, Chiun‐Sheng Huang, Daniel Egle, Cancer Research Breast OncologyPathologic Complete ResponseHigh ProliferationImmunologyImmunoediting	2020	134
Oral Immunoglobulins for Treatment of Acute Rotaviral Gastroenteritis Alfredo Guarino, Roberto Berni Canani, Stefania Russo, PEDIATRICS	1994	129
Clinical and laboratory features of 103 patients from 42 Italian families with inherited thrombocytopenia derived from the monoallelic Ala156Val mutation of GPIb (Bolzano mutation) Patrizia Noris, Silverio Perrotta, Roberta Bottega, Haematologica	2011	103
Dose prescription in carbon ion radiotherapy: How to compare two different RBE-weighted dose calculation systems Silvia Molinelli, Giuseppe Magro, Andrea Mairani, Radiotherapy and Oncology Adaptive RadiotherapyDose PrescriptionRadiation TherapyMedicineCarbon Ion Radiotherapy	2016	90
Long-Term Bioavailability After a Single Oral or Intramuscular Administration of 600,000 IU of Ergocalciferol or Cholecalciferol: Implications for Treatment and Prophylaxis Cristiana Cipriani, Elisabetta Romagnoli, Jessica Pepe, The Journal of Clinical Endocrinology & Metabolism	2013	87
Characterization of a commercial scintillation detector for 2-D dosimetry in scanned proton and carbon ion beams Stefania Russo, Alfredo Mirandola, Silvia Molinelli, Physica Medica Radiation DetectionPhysicsCalibrationScintillator2-D Dosimetry	2017	86
EGFR mutations detected on cytology samples by a centralized laboratory reliably predict response to gefitinib in non–small cell lung carcinoma patients Umberto Malapelle, Claudio Bellevicine, Caterina De Luca, Cancer Cytopathology	2013	80

Page 1